Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-related macular degeneration using a treat-and-extend regimen: a retrospective case series

BACKGROUND: The continuation of anti-vascular endothelial growth factor (anti-VEGF) treatment after achieving stability in patients with neovascular age-related macular degeneration has generally been advocated. In our own patients, we thought to assess whether continued anti-VEGF treatment is capab...

Descripción completa

Detalles Bibliográficos
Autores principales: Garweg, Justus G., Traine, Peter G., Garweg, Richard A., Wons, Juliana, Gerhardt, Christin, Pfister, Isabel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956692/
https://www.ncbi.nlm.nih.gov/pubmed/33941877
http://dx.doi.org/10.1038/s41433-021-01562-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956692/
https://www.ncbi.nlm.nih.gov/pubmed/33941877
http://dx.doi.org/10.1038/s41433-021-01562-6

Ejemplares similares